39 F
New York
HomeMedicinePsychedelic Drugs Market to Reach $2,614.1 Million, by 2032 at 13.4% CAGR:...

Psychedelic Drugs Market to Reach $2,614.1 Million, by 2032 at 13.4% CAGR: Allied Market Research

Psychedelic drugs, also known as hallucinogens, are a class of substances that can profoundly alter one’s perception, thoughts, and feelings. These substances induce vivid sensory experiences, often characterized by hallucinations, intense emotions, and a distorted sense of reality. 

PORTLAND, Ore., Nov. 28, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Psychedelic Drugs Market by Drug Type (Ketamine, Psilocybin, and Others), Application (Mental Health, Abuse Disorders, and Other), and End User (Hospitals, Mental Health Center, and Other): Global Opportunity Analysis and Industry Forecast, 2023–2032.”. According to the report, the global psychedelic drugs market was valued at $752.3 million in 2022 and is projected to reach $2,614.1 million by 2032, registering a CAGR of 13.4% from 2023 to 2032. 

Request Sample of the Report on Psychedelic Drugs Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/12433

Prime determinants of growth

 The psychedelic drugs market has experienced significant growth due to surge in prevalence of the mental health crises, rise in the research and development of psychedelics to evaluate the therapeutic effect of the psychedelics, and rise in social acceptance of the psychedelics. 

Report coverage & details: 

Report Coverage 

Details 

Forecast Period 

2023–2032 

Base Year 

2022

Market Size in 2022 

$752.3 million 

Market Size in 2032 

$2,614.1 million 

CAGR 

13.4 %

No. of Pages in Report 

240

Segments covered 

Drug Type, Application, End User, and Region. 

Drivers 

Rise in prevalence of mental illness. 

Rise in investment for the research and development of psychedelic drugs. 

Increased social acceptance of psychedelic drugs. 

Opportunities 

Rise in awareness about mental health. 

Restraints 

Safety concerns regarding the use of psychedelic drugs. 

Economic Downturn Analysis: Impact of Recession in 2023 on the Psychedelic Drugs Market 

  • The global recession has significant impact on the psychedelic drugs market. 
  • The high inflation rate and the economic uncertainty has impacted the potential investment for the new product development and research activities. 
  • However, market for psychedelic drugs market is expected to recover owing to rise in prevalence of mental illness. 

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/12433

The ketamine segment to maintain its leadership status throughout the forecast period 

Based on drug type, the ketamine segment held the highest market share in 2022, accounting for more than one third of the psychedelic drugs market revenue, owing to high adoption of ketamine for treatment of depression. 

The mental health segment to maintain its leadership status throughout the forecast period 

Based on application, the mental health segment held the highest market share in 2022, accounting for more than half of the psychedelic drugs market revenue. This is attributed to high prevalence of mental illness. 

The mental health center segment to maintain its leadership status throughout the forecast period 

Based on end user, the mental health center segment held the highest market share in 2022, accounting for more than one third of the psychedelic drugs market revenue. This is attributed to high prevalence of neurological conditions globally. 

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/12433

The North America segment to maintain its leadership status throughout the forecast period 

Based on region, the North America segment held the highest market share in 2022, accounting for more than one third of the psychedelic drugs market revenue. This is attributed to the rise in prevalence of depression and presence of major key players. 

Leading Market Players:

  • Numinus Wellness Inc
  • Enveric Biosciences 
  • Field Trip Health 
  • Johnson And Johnson (J&J) 
  • Havn Life 
  • Pharmather 
  • Psyched Wellness 
  • Apex Labs 
  • Ceruvia Lifesciences 
  • Braxia Scientific 

The report provides a detailed analysis of these key players in the psychedelic drugs market. These players have adopted different strategies such as collaboration, product approval, acquisition, funding, and partnership to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Comprehensive Healthcare Industry Research Studies:

Potential Analysis of Human DNA Vaccines Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

3D Printed Drugs Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Wearable Injectors Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

Computed Tomography (CT) Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

Empty Capsules Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research

Originally published at https://www.prnewswire.com/news-releases/psychedelic-drugs-market-to-reach-2-614-1-million-by-2032-at-13-4-cagr-allied-market-research-301999301.html
Images courtesy of https://pixabay.com

- Part of VUGA -marketing agency

latest articles

gossip tv free

explore more

free fashion tv